|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2001-5-4
|
|
pubmed:abstractText |
Salivary gland dysfunction has been described in patients undergoing radioiodine therapy but associated lacrimal gland dysfunction (sicca syndrome) has never been reported. We conducted a prospective cohort study with follow-up for up to 3 y in a tertiary care university center to determine the prevalence of sicca syndrome in patients after high-dose radioiodine treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0161-5505
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
738-43
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11337569-Adult,
pubmed-meshheading:11337569-Aged,
pubmed-meshheading:11337569-Aged, 80 and over,
pubmed-meshheading:11337569-Female,
pubmed-meshheading:11337569-Humans,
pubmed-meshheading:11337569-Iodine Radioisotopes,
pubmed-meshheading:11337569-Lacrimal Apparatus,
pubmed-meshheading:11337569-Male,
pubmed-meshheading:11337569-Middle Aged,
pubmed-meshheading:11337569-Radiation Injuries,
pubmed-meshheading:11337569-Radiotherapy Dosage,
pubmed-meshheading:11337569-Salivary Glands,
pubmed-meshheading:11337569-Sjogren's Syndrome,
pubmed-meshheading:11337569-Thyroid Neoplasms,
pubmed-meshheading:11337569-Xerophthalmia,
pubmed-meshheading:11337569-Xerostomia
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy.
|
|
pubmed:affiliation |
Department of Internal Medicine, Vall d'Hebron General Teaching Hospital, Barcelona, Spain.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
